FPHAX Mutual Fund

FPHAX Mutual Fund

NAV$39.20
See how much of FPHAX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free
Showing top 50 of 58 holdings · as of Aug 31, 2026
FPHAX holdings, by weight
#TickerNameWeightCumulativeSharesMkt valueSectorIndustry
1
LLY
Eli Lilly & CoHealth Care · Pharmaceuticals
24.47%		24.5%345,601$399.77MHealth CarePharmaceuticals
2—Gsk Plc Sponsored Adr (1 Ads : 2 Ordinary)Health Care · Pharmaceuticals
7.92%		32.4%2,576,560$129.47MHealth CarePharmaceuticals
Sector and industry · Pro
3
MRK
Merck & Company Inc
6.37%		38.8%704,636$104.12M
4
VTRS
Viatris Inc.
5.46%		44.2%5,401,100$89.17M
5—AstraZeneca PLC
4.98%		49.2%501,350$81.28M
6—Ucb Sa
4.96%		54.2%324,200$81.08M
7
BMY
Bristol-Myers Squibb Co.
4.61%		58.8%1,128,100$75.37M
8—Roche Holding Ag- Genusschein
4.57%		63.3%170,940$74.61M
9
GILD
Gilead Sciences
4.47%		67.8%499,200$73.05M
10
ELAN
Elanco Animal Health, Inc Cvr
4.26%		72.1%2,908,100$69.56M
11
JAZZ
Jazz Pharmaceuticals Plc.
4.22%		76.3%274,800$68.89M
12
LEGN
Legend Biotech Corp-adr
3.30%		79.6%2,591,700$53.86M
13
MRNA
Moderna Inc
3.20%		82.8%372,300$52.25M
14—Royalty Pharma Plc 3.55%
2.60%		85.4%692,000$42.50M
15—Biontech Se Adr
1.71%		87.1%275,553$28.00M
16
JNJ
Johnson & Johnson -
0.96%		88.1%59,100$15.71M
17
NTLA
Intellia Therapeutics Inc
0.91%		89.0%1,165,300$14.83M
18
BEAM
Beam Therapeutics Inc.
0.90%		89.9%500,600$14.73M
19
OCUL
Ocular Therapeutix Inc
0.86%		90.7%1,331,717$13.97M
20—Xenon Pharmaceuticals Inc
0.83%		91.6%226,000$13.61M
21
AXSM
Axsome Therapeutics Inc
0.76%		92.3%62,700$12.45M
22
FTBFX
Fidelity Cash Central Fund
0.65%		93.0%10,666,711$10.67M
23
KYMR
Kymera Therapeutics Inccommon Stock
0.61%		93.6%84,500$10.04M
24
AMLX
Amylyx Pharmaceuticals Inc
0.53%		94.1%257,800$8.70M
25
ELVN
Enliven Therapeutics Inc
0.51%		94.6%143,047$8.28M
26
HRMY
Harmony Biosciences, Llc
0.51%		95.1%209,977$8.27M
27
SOBIV
Swedish Orphan Biovitrum AB (publ) Shs
0.49%		95.6%170,200$7.99M
28—Definium Therapeutics, Inc. Common Shares
0.46%		96.1%188,000$7.47M
29
PTCT
Ptc Therapeutics Inc
0.42%		96.5%98,700$6.86M
30—Cash
0.40%		96.9%-$6.50M
31
ARWR
Arrowhead Pharmaceuticals Inc
0.33%		97.2%65,400$5.39M
32
CORT
Corcept Therapeutics Inc
0.31%		97.5%45,000$5.10M
33
ANNX
Annexon Inc
0.30%		97.8%1,003,800$4.96M
34
ASND
Ascendis Pharma A/S
0.29%		98.1%18,300$4.81M
35
AGMB
AgomAb Therapeutics NV Each ADS represents one common share
0.27%		98.4%332,858$4.38M
36—Serif Biomedicines Inc
0.27%		98.7%1,886,792$4.45M
37
IRON
Disc Medicine Inc
0.26%		98.9%53,800$4.23M
38—Uniqure N.V. Ordinary Shares
0.24%		99.2%80,778$3.93M
39
EWTX
Edgewise Therapeutics Inc.
0.21%		99.4%83,600$3.49M
40
ELYM
Eliem Therapeutics Inc.
0.21%		99.6%255,342$3.51M
41
IONS
Ionis Pharmaceuticals Inc
0.15%		99.7%40,100$2.42M
42DebtEvozyne Inc Cpik
0.08%		99.8%1,038,846$1.24M
43—Castle Creek Biosciences
0.07%		99.9%6,308$1.07M
44—Evozyne
0.06%		99.9%56,643$945.4K
45—Paragon Bioscien Indem Esc Pp
0.01%		100.0%201,914$171.6K
46—Paragon Bio Emalex Omba Roy Pp
0.01%		100.0%201,914$82.8K
47—Paragon Biosciences Emalex Cap
0.01%		100.0%201,914$173.6K
48—Evozyne
0.01%		100.0%5,900$95.9K
49
MDVL
Medavail Holdings Inc
0.00%		100.0%66-
50—Myos Corp Shareholder Rep Pp
0.00%		100.0%40,000-
More holdings · Pro
Not reported for this fund: share changes.
FundXLS Pro
See the other 8 holdings of FPHAX
X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.
Unlock FundXLS Pro$45/quarter Pro · Cancel anytime

FPHAX Mutual Fund All Holdings

FPHAX holdings total 59 positions. The top 10 holdings account for 72.1% of the fund, led by Eli Lilly & Co at 24.5%, Gsk Plc Sponsored Adr (1 Ads : 2 Ordinary) at 7.9%, Merck & Company Inc at 6.4%.

FPHAX portfolio concentration is relatively high, with the top 10 representing 72.1% of total assets. The largest sector exposure is Health Care at 84.8%.

FPHAX sectors provide a detailed breakdown. FPHAX overlap shows how holdings compare to other funds in your portfolio.